---
document_datetime: 2023-09-21 21:42:37
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nyxoid-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: nyxoid-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 7.92164
conversion_datetime: 2025-12-15 22:53:36.57942
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Nyxoid

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ² / amended on   | Product Information affected3   | Summary                        |
|----------------------|------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|--------------------------------|
| IG/1593              | A.1 - Administrative change - Change in the name and/oraddressoftheMAH             | 24/02/2023                          |                                            | SmPC, Labelling and PL          |                                |
| PSUSA/10657 /202205  | PeriodicSafetyUpdateEUSingleassessment- naloxone (for use in non-medical settings) | 12/01/2023                          | n/a                                        |                                 | PRACRecommendation-maintenance |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

2A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics,annex II, labelling,package leaflet).The CD is issued within twomonths of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation(EU) No.712/2012, or within one yearfor other procedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0016             | A.5.b-Administrative change -Change in the name and/or addressof amanufacturer/importerof the finished product, including quality control sites (excludingmanufacturerforbatchrelease)   | 11/11/2022   | n/a        |                                  |                                |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------------------|
| R/0014              | Renewal of themarketing authorisation.                                                                                                                                                   | 21/07/2022   | 15/09/2022 | SmPC, Annex II, Labelling and PL |                                |
| IB/0013             | C.1.11.z-Introduction of,or change(s) to, the obligations and conditions of a marketing authorisation,includingtheRMP-Othervariation                                                     | 20/12/2021   | 03/02/2022 | Annex II and PL                  |                                |
| IA/0012             | B.II.b.2.a - Change to importer, batch release arrangements andqualitycontroltestingof theFp- Replacement/additionofasitewherebatch control/testingtakesplace                            | 09/07/2021   | n/a        |                                  |                                |
| IA/0011             | A.7-Administrative change-Deletion of manufacturing sites                                                                                                                                | 05/02/2021   | 03/02/2022 | Annex II and PL                  |                                |
| PSUSA/10657 /202005 | PeriodicSafetyUpdateEUSingleassessment- naloxone(for use innon-medical settings)                                                                                                         | 26/11/2020   | n/a        |                                  | PRACRecommendation-maintenance |
| PSUSA/10657 /201905 | PeriodicSafetyUpdateEUSingleassessment- naloxone (for use in non-medical settings)                                                                                                       | 16/01/2020   | n/a        |                                  | PRACRecommendation-maintenance |
| N/0009              | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3Notification)                                                                                                    | 07/11/2019   | 09/03/2020 | PL                               |                                |

<div style=\"page-break-after: always\"></div>

| IB/0008             | C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinal Products-Othervariation                                                                                                                                                        | 09/09/2019   | n/a        |                        |                                |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|--------------------------------|
| IAIN/0006           | B.I1.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsibleforimportation and/orbatchrelease- Not including batch control/testing                     | 05/04/2019   | 09/03/2020 | Annex II and PL        |                                |
| IB/0005/G           | Thiswasanapplicationforagroupofvariations. B.II.e.z-Change in container closure system of the FinishedProduct-Othervariation B.II.f.1.z-Stability of FP-Change in the shelf-life or storageconditionsof thefinishedproduct-Other variation    | 11/03/2019   | 09/03/2020 | SmPC and PL            |                                |
| PSUSA/10657 /201805 | PeriodicSafetyUpdateEUSingle assessment- naloxone (for use in non-medical settings)                                                                                                                                                           | 17/01/2019   | n/a        |                        | PRACRecommendation-maintenance |
| T/0004              | TransferofMarketingAuthorisation                                                                                                                                                                                                              | 25/10/2018   | 22/11/2018 | SmPC, Labelling and PL |                                |
| IAIN/0002/G         | This was an applicationfor a group of variations. B.II.b.1.a-Replacementoradditionofa manufacturing site for the FP - Secondary packaging site B.II.b.1.a-Replacement or addition of a manufacturing site for the FP-Secondary packaging site | 20/03/2018   | n/a        |                        |                                |

<div style=\"page-break-after: always\"></div>

|         | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/additionofasitewherebatch control/testing takes place B.I1.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsible for importation and/or batch release - Not including batch control/testing   |            |            |      |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|
| IB/0001 | B.II.f.1.z-Stability of FP-Change in the shelf-life or storageconditionsofthefinishedproduct-Other variation                                                                                                                                                                                                                                                                                           | 10/01/2018 | 22/11/2018 | SmPC |